NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/14/2026
Back to search
Official data from USPTO
AGILENT BIOPHARMA CDX SERVICES LAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AGILENT BIOPHARMA CDX SERVICES LAB
ST13
US500000098461563Class
42
Filing
98461563
Registration
8346393
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
07/14/2026
Trademark type
Word
Nice classes
42
Filing date
03/21/2024
Registration date
07/14/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/14/2026
Last transaction
07/14/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2024-06-00
First use in commerce
2024-06-00
Drawing code
4
Owner type
03
Owner location
Santa Clara, CA, US
Examiner
RONCORONI, LAUREN R
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Agilent Technologies, Inc.
Representatives
Andrew Roppel Holland & Hart LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific laboratory services; Scientific laboratory services in the field of pharmaceuticalsbiopharmaceuticalscompanion diagnosticsbiotherapeutic products; Laboratory research services relating to pharmaceuticalsbiopharmaceuticalscompanion diagnosticsbiotherapeutic products; Pharmaceutical and biopharmaceutical drug development services; Scientific and technological consulting services in the pharmaceutical industry in the field of companion diagnosticsresearch and design relating thereto
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/14/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/25/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/25/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/02/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/01/2026
EX2G
SOU EXTENSION 2 GRANTED
05/01/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/01/2026
IUAF
USE AMENDMENT FILED
11/26/2025
EEXT
SOU TEAS EXTENSION RECEIVED
11/26/2025
EXT2
SOU EXTENSION 2 FILED
11/25/2025
EISU
TEAS STATEMENT OF USE RECEIVED
11/25/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/15/2025
EX1G
SOU EXTENSION 1 GRANTED
06/09/2025
EXT1
SOU EXTENSION 1 FILED
06/09/2025
EEXT
SOU TEAS EXTENSION RECEIVED
06/09/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/10/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/29/2024
PUBO
PUBLISHED FOR OPPOSITION
10/29/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/09/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/24/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/23/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/23/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/18/2024
GNRT
NON-FINAL ACTION E-MAILED
09/18/2024
CNRT
NON-FINAL ACTION WRITTEN
09/18/2024
DOCK
ASSIGNED TO EXAMINER
09/18/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/17/2024
NWAP
NEW APPLICATION ENTERED
03/21/2024
Continuous trademark protection
Get notified about every new filing that threatens AGILENT BIOPHARMA CDX SERVICES LAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.